小分子抑制剂-话题@MedSci

#小分子抑制剂#

11篇内容 | 1574人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2256880, encodeId=9849225688093, content=<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> <a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a> <a href='/topic/show?id=b1c512525816' target=_blank style='color:#2F92EE;'>#ZMYND8#</a>, objectTitle=Nat Cancer | 靶向 ZMYND8 抑制前列腺癌神经内分泌转分化，破解耐药难题, objectType=article, longId=867975, objectId=5ff786e97507, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240801/1722479677148_92910.jpg, objectUrl=/article/show_article.do?id=5ff786e97507, replyNumber=0, likeNumber=0, createdTime=2025-03-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=5ff786e97507, moduleTitle=Nat Cancer | 靶向 ZMYND8 抑制前列腺癌神经内分泌转分化，破解耐药难题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ff786e97507)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2253817, encodeId=5c4c225381e40, content=<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> <a href='/topic/show?id=a07f82814ec' target=_blank style='color:#2F92EE;'>#肿瘤免疫治疗#</a> <a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a> <a href='/topic/show?id=6fd3194843' target=_blank style='color:#2F92EE;'>#ADAR1#</a>, objectTitle=Nat Cancer：中国学者发布小分子ZYS-1靶向ADAR1为前列腺癌治疗带来新希望, objectType=article, longId=864695, objectId=84c4864695bc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240523/1716430494511_92910.jpg, objectUrl=/article/show_article.do?id=84c4864695bc, replyNumber=0, likeNumber=16, createdTime=2025-02-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=84c4864695bc, moduleTitle=Nat Cancer：中国学者发布小分子ZYS-1靶向ADAR1为前列腺癌治疗带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84c4864695bc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243511, encodeId=e09122435117f, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=【BioDrugs】改善CAR-T的疗效和安全性，小分子抑制剂大有可为, objectType=article, longId=855832, objectId=c13085583233, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220813/1660373278819_8252897.webp, objectUrl=/article/show_article.do?id=c13085583233, replyNumber=0, likeNumber=26, createdTime=2024-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c13085583233, moduleTitle=【BioDrugs】改善CAR-T的疗效和安全性，小分子抑制剂大有可为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c13085583233)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209759, encodeId=7e862209e5994, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a> <a href='/topic/show?id=ef345405900' target=_blank style='color:#2F92EE;'>#成纤维细胞生长因子#</a> <a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=FGFR靶向治疗的临床进展, objectType=article, longId=828983, objectId=de1a82898368, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240613/1718271607734_1608702.png, objectUrl=/article/show_article.do?id=de1a82898368, replyNumber=0, likeNumber=135, createdTime=2024-06-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=de1a82898368, moduleTitle=FGFR靶向治疗的临床进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de1a82898368)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1678220, encodeId=5da616e8220e1, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=A&R：核输出的小分子抑制剂通过调节浆细胞生成和存活来改善狼疮, objectType=article, longId=736686, objectId=6c3ae36686fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c3ae36686fc, replyNumber=0, likeNumber=131, createdTime=2023-07-21, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c3ae36686fc, moduleTitle=A&R：核输出的小分子抑制剂通过调节浆细胞生成和存活来改善狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c3ae36686fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678219, encodeId=663a16e821976, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Lancet：房颤患者采用新型FXIa小分子抑制剂Asundexian预防卒中的效果和安全性, objectType=article, longId=723521, objectId=25a3e23521c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25a3e23521c8, replyNumber=0, likeNumber=94, createdTime=2022-08-26, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25a3e23521c8, moduleTitle=Lancet：房颤患者采用新型FXIa小分子抑制剂Asundexian预防卒中的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25a3e23521c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678218, encodeId=b93916e821859, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=口服小分子抑制剂Pritelivir获得FDA授予突破性疗法称号，用于治疗免疫功能低下的单纯疱疹病毒感染, objectType=article, longId=195480, objectId=075d1954800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=075d1954800a, replyNumber=0, likeNumber=105, createdTime=2021-02-28, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=075d1954800a, moduleTitle=口服小分子抑制剂Pritelivir获得FDA授予突破性疗法称号，用于治疗免疫功能低下的单纯疱疹病毒感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=075d1954800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678217, encodeId=0dfc16e8217b5, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=CELL STEM CELL：PAPD5小分子抑制剂恢复干细胞中端粒酶活性, objectType=article, longId=193436, objectId=6d9819343645, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9819343645, replyNumber=0, likeNumber=107, createdTime=2020-08-26, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9819343645, moduleTitle=CELL STEM CELL：PAPD5小分子抑制剂恢复干细胞中端粒酶活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9819343645)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678216, encodeId=d08316e821619, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Sci Rep：GSK-3beta的小分子抑制剂9-ING-41能够增强膀胱癌治疗效果, objectType=article, longId=186332, objectId=177a18633219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=177a18633219, replyNumber=0, likeNumber=87, createdTime=2020-05-30, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=177a18633219, moduleTitle=Sci Rep：GSK-3beta的小分子抑制剂9-ING-41能够增强膀胱癌治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=177a18633219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678215, encodeId=8cef16e8215b9, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Mol Cancer Ther：MDA-9/Syntenin (SDCBP) PDZ1小分子抑制剂能够抑制前列腺癌发病机制, objectType=article, longId=177490, objectId=83ff1e7490bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ff1e7490bb, replyNumber=0, likeNumber=77, createdTime=2020-06-21, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ff1e7490bb, moduleTitle=Mol Cancer Ther：MDA-9/Syntenin (SDCBP) PDZ1小分子抑制剂能够抑制前列腺癌发病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ff1e7490bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678213, encodeId=803b16e821305, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭, objectType=article, longId=124231, objectId=8f861242312e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f861242312e, replyNumber=0, likeNumber=108, createdTime=2018-03-19, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f861242312e, moduleTitle=Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f861242312e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678214, encodeId=72b616e8214d8, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Nat Med：泛素活化酶的小分子抑制剂可以用于癌症治疗, objectType=article, longId=126769, objectId=6035126e6956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6035126e6956, replyNumber=0, likeNumber=97, createdTime=2018-12-18, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6035126e6956, moduleTitle=Nat Med：泛素活化酶的小分子抑制剂可以用于癌症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6035126e6956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678212, encodeId=52de16e8212b1, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Lancet：治疗类风湿关节炎的新型生物制剂和小分子抑制剂的新近进展。, objectType=article, longId=101445, objectId=0017101445df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0017101445df, replyNumber=0, likeNumber=87, createdTime=2018-05-18, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0017101445df, moduleTitle=Lancet：治疗类风湿关节炎的新型生物制剂和小分子抑制剂的新近进展。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0017101445df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678211, encodeId=c29016e8211e4, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=Nature Chem Bio:针对BCL-XL的高效小分子抑制剂WEHI-539被发现, objectType=article, longId=17992, objectId=9e5b1e99225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e5b1e99225, replyNumber=0, likeNumber=97, createdTime=2013-09-11, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e5b1e99225, moduleTitle=Nature Chem Bio:针对BCL-XL的高效小分子抑制剂WEHI-539被发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e5b1e99225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1678210, encodeId=adc016e821070, content=<a href='/topic/show?id=f34c46963cc' target=_blank style='color:#2F92EE;'>#小分子抑制剂#</a>, objectTitle=J Med Chem：新型Bcr-Abl小分子抑制剂有望用于慢粒性白血病耐药的治疗, objectType=article, longId=16683, objectId=fa7f16683c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa7f16683c8, replyNumber=0, likeNumber=109, createdTime=2014-02-04, rootId=0, userName=lqrandywkz, userId=3b6f27658858, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa7f16683c8, moduleTitle=J Med Chem：新型Bcr-Abl小分子抑制剂有望用于慢粒性白血病耐药的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa7f16683c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

小分子抑制剂

2020-05-29

梅斯管理员

#前列腺癌# #小分子抑制剂# #ZMYND8#

Nat Cancer | 靶向 ZMYND8 抑制前列腺癌神经内分泌转分化，破解耐药难题

2025-03-20发表于陕西省

梅斯管理员

#前列腺癌# #肿瘤免疫治疗# #小分子抑制剂# #ADAR1#

Nat Cancer：中国学者发布小分子ZYS-1靶向ADAR1为前列腺癌治疗带来新希望

2025-02-27发表于陕西省

梅斯管理员

#Car-T细胞疗法# #小分子抑制剂#

【BioDrugs】改善CAR-T的疗效和安全性，小分子抑制剂大有可为

2024-12-19发表于陕西省

梅斯管理员

#癌症治疗# #成纤维细胞生长因子# #小分子抑制剂#

FGFR靶向治疗的临床进展

2024-06-13发表于上海

lqrandywkz

#小分子抑制剂#

A&R：核输出的小分子抑制剂通过调节浆细胞生成和存活来改善狼疮

2023-07-21

lqrandywkz

#小分子抑制剂#

Lancet：房颤患者采用新型FXIa小分子抑制剂Asundexian预防卒中的效果和安全性

2022-08-26

lqrandywkz

#小分子抑制剂#

口服小分子抑制剂Pritelivir获得FDA授予突破性疗法称号，用于治疗免疫功能低下的单纯疱疹病毒感染

2021-02-28

lqrandywkz

#小分子抑制剂#

CELL STEM CELL：PAPD5小分子抑制剂恢复干细胞中端粒酶活性

2020-08-26

lqrandywkz

#小分子抑制剂#

Sci Rep：GSK-3beta的小分子抑制剂9-ING-41能够增强膀胱癌治疗效果

2020-05-30

lqrandywkz

#小分子抑制剂#

Mol Cancer Ther：MDA-9/Syntenin (SDCBP) PDZ1小分子抑制剂能够抑制前列腺癌发病机制

2020-06-21

lqrandywkz

#小分子抑制剂#

Oncotarget：PD-1 / PD-L1免疫检查点的小分子抑制剂能够减轻PD-L1诱导的T细胞耗竭

2018-03-19

lqrandywkz

#小分子抑制剂#

Nat Med：泛素活化酶的小分子抑制剂可以用于癌症治疗

2018-12-18

lqrandywkz

#小分子抑制剂#

Lancet：治疗类风湿关节炎的新型生物制剂和小分子抑制剂的新近进展。

2018-05-18

lqrandywkz

#小分子抑制剂#

Nature Chem Bio:针对BCL-XL的高效小分子抑制剂WEHI-539被发现

2013-09-11

lqrandywkz

#小分子抑制剂#

J Med Chem：新型Bcr-Abl小分子抑制剂有望用于慢粒性白血病耐药的治疗

2014-02-04

科室
- - 订阅+
  - 更多科室
工具
服务